Delivery Order SPE2DB20D3103-SPE2DB24FQ3V7

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) is to Amerisourcebergen Drug Corporation's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $2,513.65 firm fixed price delivery order is for the supply of 4,564,541,466 methylphenidate ER 18 mg tablets, with a period of performance through May 9, 2024. Amerisourcebergen holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Methylphenidate ER 27 mg tablets in 100-count bottles. The $1,820.87 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of November 21, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Methylphenidate ER 18 mg tablets. The $3,473.04 firm fixed-price delivery order has a period of performance through February 19, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of methylphenidate extended-release 54 mg tablets. The Firm Fixed Price delivery order, valued at $1,581.65, has an ultimate completion date of July 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,664.29, is a delivery order for 4566472184 - Methylphenidate ER 54 mg tablets. The award has an ultimate completion date of November 19, 2024 and uses a firm fixed price pricing type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Methylphenidate ER 54 mg tablets. The $1,936.38 firm fixed-price contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of Methylphenidate ER 18 mg tablets to the Defense Logistics Agency (DLA). The $1,768.34 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has an ultimate completion date of October 15, 2024 and does not utilize a set-aside designation. As a large indefinite delivery vehicle (IDV) contractor with the DLA Troop Support Medical, valued up to...
This federal contract award, valued at $1,355.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,604,854 units of Methylphenidate ER 18 mg tablets to support the DLA's medical supply needs. The contract has a period of performance through May 15, 2024 and was awarded on a firm-fixed price basis without any set-aside designations. Amerisourcebergen, a major pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide Methylphenidate ER 36 mg tablets in 100-count packages. The $1,897.26 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for the company to supply a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,319.97 firm fixed-price delivery order is for the supply of 4,567,193,190 units of Methylphenidate ER 18 mg tablets. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FQ3V7
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp (AmerisourceBergen) is a delivery order valued at $2,531.32 for the supply of Methylphenidate ER 18 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation, indicating open competition.

AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 9:51 AM